Impact of human immunodeficiency virus infection on progression to end-stage liver disease in individuals with hemophilia and hepatitis C virus infection

Journal of Infectious Diseases

Volumn 183, Issue 7, 2001, Pages 1112-1115

  Ragni, Margaret V ^a,b   Belle, Steven H ^c  

^a UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^b Hemophilia Center of Western Pennsylvania   (United States)

^c GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ALCOHOL CONSUMPTION; ARTICLE; DISEASE COURSE; DISEASE DURATION; HEMOPHILIA; HEPATITIS C; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LIVER FAILURE; MAJOR CLINICAL STUDY; MORTALITY; PRIORITY JOURNAL; RISK FACTOR; SUPERINFECTION;

ADULT; COHORT STUDIES; CONFIDENCE INTERVALS; DISEASE PROGRESSION; HEMOPHILIA A; HEPATITIS B SURFACE ANTIGENS; HEPATITIS C, CHRONIC; HIV INFECTIONS; HIV SEROPOSITIVITY; HUMANS; RISK; SURVIVAL ANALYSIS;

EID: 0035313557     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/319273     Document Type: Article

References (15)

1. Mortality and causes of death in Dutch haemophiliacs, 1973-86
2. The presence of hepatitis C virus (HCV) antibody in human immunodeficiency virus-positive hemophilic men undergoing HCV "seroreversion."
3. Hepatitis and clotting-factor concentrates
4. Survey of diagnostic and treatment practices of chronic hepatitis C in federally-funded hemophilia treatment centers
5. Progressive liver disease in hemophilia: An understated problem?
6. Hepatitis C virus (HCV) circulates as a population of different but closely related genomes: Quasispecies nature of HCV genome distribution
7. Lack of protective immunity against reinfection with hepatitis C virus
8. Frequent reinfection and reactivation of hepatitis C virus genotypes in multi-transfused hemophiliacs
9. A multicenter study of viral hepatitis in a United States hemophilic population
10. 1986 Update of HIV seroprevalence, seroconversion, AIDS incidence, and immunologic correlates of HIV infection in hemophiliacs
11. Immunopathogenetic mechanisms in human immunodeficiency virus (HIV) infection
12. Increase in hepatitis C virus load in hemophiliacs treated with highly active antiretroviral therapy
13. Immunosuppression may lead to progression of hepatitis C virus-associated liver disease in hemophiliacs coinfected with HIV
14. Regression models and life tables
15. Interleukin 10 treatment reduces fibrosis in patients with chronic hepatitis C: A pilot trial of interferon nonresponders